The retina and the kidney share many developmental and disease-related abnormalities. Modulation of apoptosis is critical during development. Bcl-2 protects cells from apoptosis while Bim expression facilitates this process. The current focus of our laboratory is to understand the role apoptotic processes play in retinal and kidney vascular development and how they are aberrantly regulated during disease. Our ability to examine abnormalities in both organs, in parallel, enhances the design of appropriate treatment modalities for retinal or renal disease without compromising renal or retinal function.
Apoptosis plays an important role during formation of the vascular network and pathological neovascularization. However, the physiological role Bcl-2 family members play during these processes requires further delineation. Mice deficient in Bcl-2 develop renal hypoplasia/cystic dysplasia. Renal hypoplasia/dysplasia/aplasia are the second leading cause of renal transplantation in children and is commonly lethal. More recently our research has focused on the role bcl-2 family members play during postnatal retinal vascularization and retinal and choroidal neovascularization (CNV), as occurs in retinopathy of prematurity (ROP) and age-related macular degeneration (AMD). Both ROP and AMD are major causes of blindness in the United States and the underlying mechanisms remain poorly understood.
The research in our laboratory exploits our unique ability to study both retinal and renal developmental changes and isolate vascular and non-vascular cells from transgenic mice to study in tandem. Our novel research has demonstrated that expression of Bcl-2 family member proteins not only impacts cell death but also many other cell specific functions. The ability of pro- and anti-apoptotic proteins to influence these cell functions could have implications during development and disease. Alterations in cellular functions may lead to abnormal retinal and kidney development and various disease states. The knowledge gained from our studies will allow us to better understand the regulatory mechanisms in these organs and their alteration with various pathologies will aid the design of treatment modalities to intervene at earlier stages of disease preventing their development and progression with no or limited off target effects.
- Determine the role Bcl-2 plays during choroidal and retinal neovascularization.
- Determine the role Bim expression plays during postnatal retinal vascular development and remodeling.
- Determine whether Bim expression is critical for hyperoxia-mediated retinal vessel obliteration.
- Determine the protective role of Bcl-2 in lungs during hyperoxia-induced damage due to oxidative stress.
Ryan Coller, MD, MPH, Principal Investigator, and Nicole Werner, PhD (Industrial & Systems Engineering), Co-PI, and Mary Ehlenbach, MD, Collaborator, were recently awarded a one-year, $75,000 grant from the UW Institute for Clinical and Translational …September 3, 2019
Congratulations to Christine Sorenson, PhD, who was recently awarded a Vilas Life Cycle Professorship, supported by the Women in Science & Engineering Leadership Institute (WISELI) and the UW Office of the Provost. This 16-month award, …February 1, 2019
The Department of Pediatrics Research and Development Committee recently awarded grants to six faculty members for the following projects: Awni Al-Subu, MD – UW Pediatric Critical Care Point-of-Care Ultrasound Program Pelin Cengiz, MD – Epigenetic …March 1, 2017
Congratulations to Christine Sorenson, PhD, who recently received the title of “Distinguished Scientist” by the UW School of Medicine and Public Health, in recognition of her pivotal role in helping to strengthen the reputation of …February 1, 2017
The Department of Pediatrics Research and Development Committee recently awarded grants to thirteen faculty members for the following projects: Awni Al-Subu, MD – Pediatric Acute Respiratory Distress Incidence and Epidemiology (PARDIE) Study Pelin Cengiz, MD …May 1, 2016
- More News...